Details for New Drug Application (NDA): 020815
✉ Email this page to a colleague
The generic ingredient in EVISTA is raloxifene hydrochloride. There are seventeen drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the raloxifene hydrochloride profile page.
Summary for 020815
Tradename: | EVISTA |
Applicant: | Lilly |
Ingredient: | raloxifene hydrochloride |
Patents: | 0 |
Pharmacology for NDA: 020815
Mechanism of Action | Selective Estrogen Receptor Modulators |
Medical Subject Heading (MeSH) Categories for 020815
Suppliers and Packaging for NDA: 020815
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
EVISTA | raloxifene hydrochloride | TABLET;ORAL | 020815 | NDA | Eli Lilly and Company | 0002-4184 | 0002-4184-30 | 30 TABLET in 1 BOTTLE (0002-4184-30) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 60MG | ||||
Approval Date: | Dec 9, 1997 | TE: | AB | RLD: | Yes |
Expired US Patents for NDA 020815
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Lilly | EVISTA | raloxifene hydrochloride | TABLET;ORAL | 020815-001 | Dec 9, 1997 | ⤷ Sign Up | ⤷ Sign Up |
Lilly | EVISTA | raloxifene hydrochloride | TABLET;ORAL | 020815-001 | Dec 9, 1997 | ⤷ Sign Up | ⤷ Sign Up |
Lilly | EVISTA | raloxifene hydrochloride | TABLET;ORAL | 020815-001 | Dec 9, 1997 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription